Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
FRA:DR0

Deutsche Rohstoff AG Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
43.70€
+0.700 (+1.63%)
At Close: May 08, 2024
Forecast Earnings Dividends Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 37.00€ 45.10€ Wednesday, 8th May 2024 DR0.F stock ended at 43.70€. This is 1.63% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 2.10% from a day low at 42.90€ to a day high of 43.80€.
90 days 29.65€ 45.10€
52 weeks 25.80€ 45.10€

Historical Deutsche Rohstoff AG prices

Date Open High Low Close Volume
May 08, 2024 43.20€ 43.80€ 42.90€ 43.70€ 10 191
May 07, 2024 43.00€ 43.40€ 42.50€ 43.00€ 7 113
May 06, 2024 43.00€ 43.40€ 42.00€ 43.10€ 17 133
May 03, 2024 43.00€ 43.50€ 42.00€ 42.60€ 11 108
May 02, 2024 43.80€ 44.20€ 43.00€ 43.60€ 7 799
Apr 30, 2024 44.70€ 44.80€ 43.70€ 43.80€ 12 901
Apr 29, 2024 45.00€ 45.00€ 44.00€ 44.60€ 19 588
Apr 26, 2024 42.40€ 45.00€ 42.10€ 44.90€ 30 380
Apr 25, 2024 43.50€ 43.70€ 41.40€ 42.40€ 15 789
Apr 24, 2024 44.20€ 44.50€ 42.30€ 43.20€ 15 228
Apr 23, 2024 44.70€ 45.10€ 43.10€ 44.10€ 27 220
Apr 22, 2024 41.70€ 44.50€ 41.70€ 44.10€ 35 725
Apr 19, 2024 41.70€ 42.70€ 41.70€ 42.50€ 23 506
Apr 18, 2024 40.80€ 41.80€ 40.80€ 41.70€ 22 315
Apr 17, 2024 40.00€ 41.00€ 39.80€ 40.50€ 20 549
Apr 16, 2024 40.50€ 40.50€ 39.10€ 39.60€ 13 846
Apr 15, 2024 40.50€ 41.00€ 39.60€ 40.80€ 13 911
Apr 12, 2024 40.50€ 41.00€ 39.50€ 40.00€ 16 828
Apr 11, 2024 39.50€ 40.60€ 39.00€ 40.40€ 30 283
Apr 10, 2024 37.70€ 39.80€ 37.40€ 39.20€ 25 507
Apr 09, 2024 37.10€ 38.00€ 37.00€ 37.80€ 8 780
Apr 08, 2024 37.00€ 37.80€ 37.00€ 37.00€ 7 587
Apr 05, 2024 35.50€ 37.30€ 35.40€ 37.30€ 15 180
Apr 04, 2024 35.50€ 36.00€ 35.50€ 35.90€ 5 209
Apr 03, 2024 35.00€ 35.50€ 34.20€ 35.50€ 8 410
Click to get the best stock tips daily for free!

About Deutsche Rohstoff AG

Deutsche Rohstoff AG Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... DR0.F Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT